These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2842266)

  • 21. [Effectiveness and side effects of low-molecular weight heparin-dihydroergotamine in preventing thromboembolism in abdominal surgery].
    Voigt J; Hamelmann H; Hedderich J; Seifert J; Buchhammer T; Köhler A
    Zentralbl Chir; 1986; 111(21):1269-305. PubMed ID: 3544605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An international multicentre study: Clivarin in the prevention of venous thromboembolism in patients undergoing general surgery. Report of the International Clivarin Assessment Group.
    Boneu B
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S21-2. PubMed ID: 8180325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis.
    Naz R; Naz S; Mehboob M; Khalid GH
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):601-4. PubMed ID: 19810295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-course of anti-Xa effects of calcium heparin and low-molecular-weight heparin given s.c.: insights for thrombosis prevention.
    Romeo G; Salanitri G; Catania G
    Drugs Exp Clin Res; 1988; 14(6):423-7. PubMed ID: 2850903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
    Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
    BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of continuous low-dose intravenous heparin administered during operation on postoperative measurements of antithrombin III and antifactor Xa.
    Jennings SA; Heather BP; Greenhalgh RM
    Surgery; 1984 Sep; 96(3):550-5. PubMed ID: 6474360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose heparin and deep-vein thrombosis after total hip replacement.
    Mannucci PM; Citterio LE; Panajotopoulos N
    Thromb Haemost; 1976 Aug; 36(1):157-64. PubMed ID: 1036806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prophylactic and therapeutic use of a low molecular weight heparin fraction, CY 216].
    Roussi J; Houbouyan L; Tereschenko C; Alterescu R; François D; Toulemonde F; Goguel A
    J Mal Vasc; 1987; 12 Suppl B():123-7. PubMed ID: 2834483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of APTT monitoring of low-dose heparin dosage in hip surgery.
    Poller L; Taberner DA; Sandilands DG; Galasko CS
    Thromb Haemost; 1982 Feb; 47(1):50-3. PubMed ID: 7071805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.
    Adolf J; Fritsche HM; Haas S; Hennig FF; Horbach T; Kastl S; Koppenhagen K; Michaelis HC; Rhamanzadeh R; Summa W; Wagner W; Weber U; Wolf H
    Int Angiol; 1999 Jun; 18(2):122-6. PubMed ID: 10424367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of postoperative deep vein thrombosis by a combination of subcutaneous heparin with subcutaneous dihydroergotamine or oral sulphinpyrazone.
    Veth G; Meuwissen OJ; van Houwelingen HC; Sixma JJ
    Thromb Haemost; 1985 Oct; 54(3):570-3. PubMed ID: 4089792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
    Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secondary prevention after deep venous thrombosis. Low molecular weight heparin versus coumarin].
    Hamann H
    Zentralbl Chir; 1999; 124(1):24-6. PubMed ID: 10091293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A low molecular weight heparin (KABI 2165) for prophylaxis of postoperative deep venous thrombosis.
    Onarheim H; Lund T; Heimdal A; Arnesjø B
    Acta Chir Scand; 1986 Oct; 152():593-6. PubMed ID: 3544625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tolerability in ophthalmologic surgery of CY 216 in preventing venous thrombosis of the leg].
    Morin Y; Limon S
    J Fr Ophtalmol; 1988; 11(11):747-52. PubMed ID: 2855075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prophylaxis for deep vein thrombosis with low molecular weight heparin following hip and knee surgery].
    Li XL; Lu WJ; Yu NS
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):39-41. PubMed ID: 12563929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group.
    Br J Surg; 1988 Nov; 75(11):1058-63. PubMed ID: 2905187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategy for the development of the low molecular weight heparin fraction CY 216 in the prevention of postoperative deep vein thromboses in general surgery.
    Toulemonde F
    Semin Thromb Hemost; 1989 Oct; 15(4):395-400. PubMed ID: 2554500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of the efficacy and tolerance of Kabi 2165 and standard heparin in the prevention of deep venous thrombosis in total hip prosthesis].
    Barre J; Pfister G; Potron G; Droulle C; Baudrillard JC; Barbier P; Kher A
    J Mal Vasc; 1987; 12 Suppl B():90-5. PubMed ID: 2834500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of low-molecular heparin on blood coagulation].
    Harenberg J; de Vries JX; Weber E; Zimmermann R
    Dtsch Med Wochenschr; 1984 Jun; 109(24):951-4. PubMed ID: 6734448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.